Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes

Diabetes

Volumn 51, Issue 11, 2002, Pages 3300-3305

  Colhoun, Helen M ^a,e   Taskinen, Marja Riitta ^b   Otvos, James D ^c   Van Den Berg, Paul ^d   O'Connor, John ^b   Van Tol, Arie ^d  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF HELSINKI   (Finland)

^c LIPOSCIENCE INC   (United States)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN;

ADULT; ARTICLE; ASSAY; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROIMMUNOASSAY; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN METABOLISM; TURBIDIMETRY;

EID: 0036829098     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.11.3300     Document Type: Article

References (30)

1. Rye KA, Clay MA, Barter PJ: Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 145:227-238, 1999
2. Jauhiainen M, Metso J, Pahlman R, Blomqvist S, van Tol A, Ehnholm C: Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 268:4032-4036, 1993
3. Foger B, Santamarina Fojo S, Shamburek RD, Parrot CL, Talley GD, Brewer HB Jr: Plasma phospholipid transfer protein: adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J Biol Chem 272:27393-27400, 1997
4. van Haperen R, van Tol A, Vermeulen P, Jauhiainen M, van Gent T, van den BP, Ehnholm S, Grosveld F, van der KA, de Crom R: Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 20:1082-1088, 2000
5. Lagrost L, Athias A, Herbeth B, Guyard-Dangremont V, Artur Y, Paille F, Gambert P, Lallemant C: Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins: Physiological relevance in alcoholic patients. J Biol Chem 271:19058-19065, 1996
6. Murdoch SJ, Carr MC, Hokanson JE, Brunzell JD, Albers JJ: PLTP activity in premenopausal women: Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. J Lipid Res 41:237-244, 2000
7. Tahvanainen E, Jauhiainen M, Funke H, Vartiainen E, Sundvall J, Ehnholm C: Serum phospholipid transfer protein activity and genetic variation of the PLTP gene. Atherosclerosis 146:107-115, 1999
8. Colhoun HM, Scheek LM, Rubens MR, Van Gent T, Underwood SR, Fuller JH, Van Tol A: Lipid transfer protein activities in type 1 diabetic patients without renal failure and non-diabetic controls and their association with coronary artery calcification. Diabetes 50:652-659, 2001
9. Kahri J, Groop PH, Viberti G, Elliott T, Taskinen MR: Regulation of apolipoprotein A-I-containing lipoproteins in IDDM. Diabetes 42:1281-1288, 1993
10. Colhoun HM, Otvos JD, Rubens MB, Taskinen M-R, Underwood SR, Fuller JH: Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 51:1949-1956, 2002
11. Jiang XC, Qin S, Qiao C, Kawano K, Lin M, Skold A, Xiao X, Tall AR: Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med 7:847-852, 2001
12. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475, 1974
13. Fossati P, Prencipe L: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-2080, 1982
14. Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N, Miyauchi K: Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem 41:717-723, 1995
15. Speijer H, Groener JE, van Ramshorst E, van Tol A: Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis 90:159-168, 1991
16. Dullaart RP, Riemens SC, Scheek LM, van Tol A: Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes. Eur J Clin Invest 29:663-671, 1999
17. Otvos JD: Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. In Handbook of Lipoprotein Testing. Rifai N, Warnick GR, Dominiczak MH, Eds. Washington, DC, AACC Press, 2000, p. 609-223
18. Tilly-Kiesi M, Kahri J, Pyorala T, Puolakka J, Luotola H, Lappi M, Lahdenpera S, Taskinen MR: Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women. Atherosclerosis 129:249-259, 1997
19. Channon KM, Clegg RJ, Bhatnagar D, Ishola M, Arrol S, Durrington PN: Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer. Atherosclerosis 80:217-226, 1990
20. Settasatian N, Duong M, Curtiss LK, Ehnholm C, Jauhiainen M, Huuskonen J, Rye KA: The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein. J Biol Chem 276:26808-26905, 2001
21. Jiang XC, Bruce C, Mar J, Lin M, Ji Y, Francone OL, Tall AR: Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 103:907-914, 1999
22. Ehnholm S, van Dijk KW, van't HB, van der ZA, Olkkonen VM, Jauhiainen M, Hofker M, Havekes L, Ehnholm C: Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J Lipid Res 39:1248-1253, 1998
23. Lagrost L, Mensink RP, Guyard-Dangremont V, Tenune EH, Desrumaux C, Athias A, Hornstra G, Gambert P: Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids. Atherosclerosis 142:395-402, 1999
24. Cheung MC, Wolfbauer G, Brown BG, Albers JJ: Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease. Atherosclerosis i42: 201-205, 1999
25. Mero N, van Tol A, Scheek LM, van Gent T, Labeur C, Rosseneu M, Taskinen MR: Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: Relations with lipid transfer proteins and LCAT activities. J Lipid Res 39:1493-1502, 1998
26. Desrumaux C, Athias A, Bessede G, Verges B, Farnier M, Persegol L, Gambert P, Lagrost L: Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA. Arterioscler Thromb Vasc Biol 19:266-275, 1999
27. Huuskonen J, Olkkonen VM, Ehnholm C, Metso J, Julkunen I, Jauhiainen M: Phospholipid transfer is a prerequisite for PLTP-mediated HDL conversion. Biochemistry 39:16092-16098, 2000
28. van Tol A, Ligtenberg JJ, Riemens SC, van Haeften TW, Reitsma WD, Dullaart RP: Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men. Scand J Clin Lab Invest 57:147-157, 1997
29. Riemens SC, van Tol A, Sluiter WJ, Dullaart RPF: Plasma phospholipid transfer protein activity is related to insulin resistance: Impaired acute lowering by insulin in obese NIDDM patients. Diabetologia 41:929-934, 1998
30. Pussinen PJ, Jauhiainen M, Ehnholm C: ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion. J Lipid Res 38:12-21, 1997